Sponsors (2)
Expresses findings on dystonia, urges greater awareness, research, diagnosis, treatment access, and recognition of DoD/VA roles; does not create new programs or funds.
The resolution raises visibility and could spur research and improved care for people with dystonia—especially veterans—but it creates expectations and potential trade-offs without committing new funding or resources.
People with dystonia — including civilian patients and veterans — could benefit from increased research and awareness, leading to better diagnosis, treatments, and support.
Medical researchers and clinicians would gain from heightened recognition of dystonia, which can support outreach, education, and expanded scientific study.
The resolution acknowledges existing federal research programs (e.g., DoD Peer Reviewed Medical Research Program), which could facilitate coordination and pathways for continued or expanded funding.
Patients and families may have raised expectations for new treatments or services even though the resolution does not authorize or appropriate funding — improvements are not guaranteed.
If no new appropriations are provided, focusing attention on dystonia could redirect limited research dollars away from other conditions, affecting researchers and competing patient groups.
Highlighting servicemembers' and veterans' increased risk may create expectations for expanded VA/DoD services that would require resources to implement if those expectations are acted on.
Based on analysis of 2 sections of legislative text.
Official title: Expressing support for the designation of September as "Dystonia Awareness Month" to promote public awareness and understanding of dystonia.
Introduced September 17, 2025 by James E. Banks · Last progress September 17, 2025
Recognizes dystonia as a neurological movement disorder that causes involuntary muscle contractions and abnormal postures, highlights its impact on daily life, and calls for increased awareness, research, diagnosis, treatment options, and support services. The text notes the estimated U.S. prevalence (250,000–300,000), the range of clinical forms and harms, available symptom-management treatments, and the role of the Department of Defense and Department of Veterans Affairs in research and care for servicemembers and veterans. The resolution is a findings/preamble-style measure that does not create new programs or appropriate funds; it emphasizes the need for outreach, education, and continued research, and recognizes existing research funding efforts such as DoD’s Peer Reviewed Medical Research Program.